Editorial: Antenatal Parvovirus Infection: Clinical Implications

Pediatric Hematology and Oncology

Volumn 15, Issue 1, 1998, Pages 7-10

  Tchernia, G ^a  

^a BICÊTRE HOSPITAL   (France)

Author keywords

abnormalities; fetus; human parvovirus B19 infection; neonate

Indexed keywords

IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; VIRUS ANTIBODY; VIRUS DNA;

BLOOD; EDITORIAL; FEMALE; FETUS DISEASE; HUMAN; IMMUNOLOGY; ISOLATION AND PURIFICATION; NEWBORN; PARVOVIRUS; PATHOPHYSIOLOGY; PREGNANCY; PREGNANCY COMPLICATION; PREMATURITY; VIRUS INFECTION;

ANTIBODIES, VIRAL; DNA, VIRAL; FEMALE; FETAL DISEASES; HUMANS; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; INFANT, NEWBORN; INFANT, PREMATURE; PARVOVIRIDAE INFECTIONS; PARVOVIRUS B19, HUMAN; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS;

EID: 0031601554     PISSN: 08880018     EISSN: 15210669     Source Type: Journal    
DOI: 10.3109/08880019809009503     Document Type: Editorial

References (30)

1. Wiersbitzky S KW, Beyersdorff E, Mueller C, Bruns R, Eberhard B, Burtzlaff C, Wiersbitzky H. Perinatal parvovirus B19 infections: what are the clinical consequences?. Pediatr Hemalol Oncol 1997; 14: 589 – 592
2. Pattison J R., Jones S E., Hodgson J, et al. Parvovirus infection and hypoplastic crisis in sickle cell anaemia. Lancet 1981; 1: 664 – 665
3. Sergeant G R., Topley J M., Mason K, et al. Outbreak of aplastic crises in sickle cell anaemia associated with parvovirus-like agent. Lancet 1981; 2: 595 – 597
4. Anderson M J., Lewis E, Kidd I M., et al. An outbreak of erythema infectiosum associated with human parvovirus infection. J Hyg Camb 1984; 93: 85 – 93
5. Kurtzman G J., Ozawa K, Cohen B J., et al. Chronic bone marrow failure due to persistent B19 parvovirus infection. N Engl J Med 1987; 317: 287 – 294
6. Kurtzman G J., Cohen B J., Field A M., et al. Immune response to B19 parvovirus infection and an antibody defect in persistent viral infection. J. Clin Invest 1989; 84: 1114 – 1123
7. Cartron J, Bader-Meunier B, Deplanche M, et al. Human parvovirus B19-associated childhood autoimmune neutropenia. Int J Pediatr Hemalol Oncol 1995; 2: 471 – 475
8. Murray J C., Morad A B., Pierce M A., Mihms S. Thrombocytopenia accompanying early postnatal infection by human parvovirus B19. Am J Hemalol 1995; 49: 360, Letter
9. Török T J. Parvovirus B19 and human disease. Adv Intern Med 1992; 37: 431 – 455
10. Nocton J J., Miller L C., Tucker L B., Schaller J G. Human parvovirus B19-associated arthritis in children. J Pediatr 1993; 122: 186 – 190
11. Söderlund M, von Essen R, Haapasaari J, et al. Persistence of parvovirus B19 DNA in synovial membranes of young patients with and without chronic arthropathy. Lancet 1997; 349: 1063 – 1065
12. Donders G GG, van Lierde S, van Elsacker-Niele A M., et al. Survival after intrauterine parvovirus infection with persistence in early infancy: a two-year follow-up. Pediatr Infect Dis 1994; 13: 234 – 235
13. Brown K E., Anderson S M., Young N S. Erythrocyte P antigen: cellular receptor for B19 parvovirus. Science 1993; 262: 114 – 117
14. Brown K E., Hibbs J R., Gallinalla G, et al. Resistance to parvovirus B19 infection due to lack of virus receptor (erythrocyte P antigen). N Engl J Med 1994; 330: 1192 – 1196
15. Porter H J., Quantrill A M., Fleming K A. B19 parvovirus infection of myocardial cells. Lancet 1988; 1: 535 – 536
16. Saint-Martin J, Choulot J J., Bonnaud E, et al. Myocarditis caused by parvovirus. J Pediatr 1990; 116: 1007 – 1008
17. Barton L L., Lax D, Shehab Z M., Keith J C. Congenital cardiomyopathy associated with human parvovirus B19 infection. Am Heart J 1997; 133: 131 – 133
18. von dem Borne A EG, Bos M JE, Joustra-Maas N, et al. A murine monoclonal IgM antibody specific for blood group P antigen (globoside). Br J Haematol 1986; 63: 35 – 46
19. Finkel T H., Török T J., Ferguson P J., et al. Chronic parvovirus B19 infection and systemic necrotising vasculitis: opportunistic infection or aetiologic agent. Lancet 1994; 343: 1255 – 1258
20. Gratacos E, Torres P J., Vidal J, et al. The incidence of human parvovirus B19 infection during pregnancy and its impact on perinatal outcome. J Infect Dis 1995; 171: 1360 – 1363
21. Kinney J S., Anderson L J., Farrar J, et al. Risk of adverse outcomes of pregnancy after human parvovirus B19 infection. J Infect Dis 1988; 157: 663 – 667
22. Katz V L., McCoy M C., Kuller J A., Hansen W F. An association between fetal parvovirus B19 infection and fetal anomalies: a report of two cases. Am J Perinatal 1996; 13: 43 – 45
23. Hartwig N G., Vermeij-Keers C, van Elsacker-Niele A MW, et al. Embryonic malformations in a case of intrauterine parvovirus B19 infection. Teratology 1989; 39: 295 – 302
24. Tiessen R G., van Elsacker-Niele A MW, Vermeij-Keers C, et al. A fetus with a parvovirus B19 infection and congenital anomalies. Prenat Diagn 1994; 14: 173 – 176
25. Weiland H T., Vermey-Keers C, Salimans M MM, et al. Parvovirus B19 associated with fetal abnormality. Lancet 1989; 1: 682 – 683, Letter
26. Public Health Laboratory Service Working Party on Fifth Disease. Prospective study of human parvovirus (B19) infection in pregnancy. Br Med J 1990; 300: 1166 – 1170
27. Clewley J P., Cohen B J., Field A M. Detection of parvovirus B19 DNA, antigen, and particles in the human fetus. J Med Virol 1987; 23: 367 – 376
28. Caul E O., Usher M J., Burton P A. Intrauterine infection with human parvovirus B19: a light and electron microscopy study. J Med Virol 1988; 24: 55 – 66
29. Morey A L., Fleming K A. Immunophenotyping of fetal haemopoietic cells permissive for human parvovirus B19 replication in vitro. Br J Haematol 1992; 82: 302 – 309
30. White F V., Jordan J, Dickman P S., Knisely A S. Fetal parvovirus B19 infection and liver disease of antenatal onset in an infant with Ebstein's anomaly. Pediatr Pathol Lab Med 1995; 15: 121 – 129